KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Convertible Debt (2020 - 2025)

Historic Convertible Debt for Neogenomics (NEO) over the last 6 years, with Q4 2025 value amounting to $341.9 million.

  • Neogenomics' Convertible Debt rose 44.75% to $341.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $341.9 million, marking a year-over-year increase of 44.75%. This contributed to the annual value of $341.9 million for FY2025, which is 44.75% up from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Convertible Debt is $341.9 million, which was up 44.75% from $341.5 million recorded in Q3 2025.
  • Neogenomics' 5-year Convertible Debt high stood at $538.9 million for Q1 2024, and its period low was $339.6 million during Q2 2024.
  • Over the past 5 years, Neogenomics' median Convertible Debt value was $532.1 million (recorded in 2021), while the average stood at $466.8 million.
  • Per our database at Business Quant, Neogenomics' Convertible Debt skyrocketed by 22275.68% in 2021 and then crashed by 3677.87% in 2025.
  • Neogenomics' Convertible Debt (Quarter) stood at $532.5 million in 2021, then increased by 0.53% to $535.3 million in 2022, then increased by 0.54% to $538.2 million in 2023, then tumbled by 36.76% to $340.3 million in 2024, then increased by 0.45% to $341.9 million in 2025.
  • Its Convertible Debt was $341.9 million in Q4 2025, compared to $341.5 million in Q3 2025 and $341.1 million in Q2 2025.